Submit for the Fierce Pharma Marketing Awards - Deadline ends this Friday, July 3rd

CRO

Ebola Ebola test
Favicon Fierce Biotech

Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO

Officials are planning to study Mapp Biopharmaceutical’s MBP134 and Gilead Sciences’ remdesivir, which saw widespread use against COVID-19.
Eric Sagonowsky Jun 24, 2026 3:03pm
sold
Favicon Fierce Biotech

Charles River sells CDMO and discovery assets in strategic pivot

Feb 25, 2026 1:54pm
AI
Favicon Fierce Biotech

BMS and Evinova pen global development partnership

Feb 9, 2026 2:33pm
Charles River Boston Massachusetts
Favicon Fierce Biotech

Charles River to close Maryland CDMO site, lay off 20 staffers

Feb 3, 2026 12:20pm
VanNaarden
Favicon Fierce Biotech

Lilly oncology head weighs in on FDA cancer drug policies

Oct 21, 2025 11:53am
Novo
Favicon Fierce Biotech

Novo Nordisk vs. KBP: From $1.3B deal to legal battlefield

Oct 2, 2025 3:00am